PO.6.127 Efavaleukin alfa, a novel IL-2 mutein, selectively expands regulatory t cells in patients with SLE: final results of a phase 1b multiple ascending dose study

N Tchao; N Sarkar; X Hu; R Zhang; C Milmont; Y Shi Jin; V Chow; M Kroenke; K Gorski; R Furie; K Alan; C Stanley

doi:10.1136/lupus-2022-elm2022.148

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Archive

Authors

About

Podcasts
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

PDF

Friday 07 October 2022 from 13:00 to 14:10

Po.6 E- poster session 6: management and recommendations, old and new therapies/biologics

PO.6.127 Efavaleukin alfa, a novel IL-2 mutein, selectively expands regulatory t cells in patients with SLE: final results of a phase 1b multiple ascending dose study

Online download statistics by month:

Online download statistics by month: September 2022 to March 2023

	Abstract	Pdf
Sep 2022	60	10
Oct 2022	152	20
Nov 2022	750	21
Dec 2022	43	5
Jan 2023	105	6
Feb 2023	131	18
Total	1241	80

Log in using your username and password

Main menu

Log in using your username and password

You are here

Online download statistics by month:

Online download statistics by month: September 2022 to March 2023

Read the full text or download the PDF:

Log in using your username and password